NAVLE Urinary

Canine Renal Tubular Disease Study Guide

📅 March 28, 2026 ⏱ 25 min read

Overview and Clinical Importance

Renal tubular diseases represent a heterogeneous group of disorders affecting the tubular segments of the nephron, resulting in impaired reabsorption of essential solutes or defective secretion of metabolic waste products. Unlike glomerular diseases that primarily affect filtration, tubular disorders disrupt the critical processes of reabsorption, secretion, and concentration that occur along the proximal tubule, loop of Henle, and distal nephron segments.

The clinical significance of renal tubular disease in dogs lies in its often subtle presentation, frequently masquerading as other conditions such as diabetes mellitus. The hallmark finding of glucosuria with normoglycemia is pathognomonic for proximal tubular dysfunction and should immediately trigger consideration of Fanconi syndrome or other tubular disorders.

Segment	Primary Functions	Dysfunction Manifestations
Proximal Tubule	Glucose, amino acids, bicarbonate, phosphate reabsorption; organic acid secretion	Glucosuria, aminoaciduria, phosphaturia, proximal RTA (Type 2)
Loop of Henle	Countercurrent multiplication; concentrating ability; Na/K/2Cl transport	Impaired urine concentration; isosthenuria; Bartter-like syndrome
Distal Tubule	Fine-tuning Na reabsorption; Ca reabsorption (PTH-mediated); thiazide-sensitive NCC	Gitelman-like syndrome; hypocalciuria; metabolic alkalosis
Collecting Duct	H+ secretion; K+ secretion; water reabsorption (ADH-mediated via aquaporin-2)	Distal RTA (Type 1); nephrogenic diabetes insipidus; hyperkalemia

Functional Anatomy of Renal Tubules

The nephron tubular system processes approximately 160-180 liters of ultrafiltrate daily, ultimately producing only 1-2 liters of urine. Understanding the specialized functions of each tubular segment is essential for recognizing patterns of tubular dysfunction.

Proximal Convoluted Tubule (PCT)

The PCT is lined by simple cuboidal epithelial cells with prominent brush borders containing millions of microvilli that dramatically increase surface area for reabsorption. This segment is responsible for:

Reabsorption of 65% of filtered sodium, water, and chloride
100% reabsorption of glucose via SGLT2 and SGLT1 transporters
100% reabsorption of amino acids
85-90% reabsorption of bicarbonate
Reabsorption of phosphate, potassium, and small proteins

Tubular Segment Functions Summary

High-YieldThe proximal tubule is highly susceptible to ischemic and toxic injury due to its high metabolic demand and limited anaerobic capacity. Aminoglycosides, heavy metals, and various toxins preferentially damage this segment due to active uptake via megalin-cubilin receptor complex.

Breed	Typical Age of Onset	DNA Test Available
Basenji	4-7 years (range: 2-12)	Yes (OFA, UC Davis VGL)
Norwegian Elkhound	Variable	No
Shetland Sheepdog	Variable	No
Miniature Schnauzer	Variable	No

Fanconi Syndrome

Fanconi syndrome is a generalized proximal tubular dysfunction characterized by impaired reabsorption of multiple solutes including glucose, amino acids, phosphate, bicarbonate, uric acid, sodium, and potassium. This results in excessive urinary losses of these substances despite normal plasma concentrations.

Etiology and Breed Predisposition

Inherited Fanconi Syndrome

The Basenji is the breed most commonly affected by inherited Fanconi syndrome, with approximately 10-16% of North American Basenjis affected. The disease is inherited as an autosomal recessive trait caused by a 317 bp deletion in the FAN1 gene (Fanconi-associated nuclease 1) on canine chromosome 3. Clinical signs typically emerge between 4-7 years of age, though onset can range from 2-12 years.

Breeds with Reported Inherited Fanconi Syndrome

Acquired Fanconi Syndrome

Acquired causes can affect any breed and include:

NAVLE TipJerky treat-associated Fanconi syndrome (primarily from Chinese-manufactured chicken, duck, or sweet potato jerky treats) has affected over 1,000 dogs in North America. Clinical signs may appear within days to months of ingestion. The causative agent remains unidentified despite extensive FDA investigation. Key point: This form is often REVERSIBLE with treat withdrawal and supportive care!

Clinical Signs

The clinical presentation varies based on severity and duration of tubular dysfunction. Signs may be subtle early in the disease course.

Diagnostic Approach

Pathognomonic Finding

GLUCOSURIA WITH NORMOGLYCEMIA = THINK FANCONI SYNDROME - This finding should ALWAYS prompt consideration of proximal tubular dysfunction. Glucose appears in urine despite normal blood glucose because the proximal tubule fails to reabsorb filtered glucose.

Diagnostic Tests

Treatment and Management

Treatment must be individualized based on severity of electrolyte and acid-base disturbances. The Gonto Protocol is widely used for managing inherited Fanconi syndrome in Basenjis.

Prognosis

Inherited Fanconi syndrome (Basenji): With appropriate management using the Gonto Protocol, dogs can achieve near-normal lifespan. Without treatment, progression to end-stage renal failure typically occurs. Early diagnosis before severe metabolic derangements improves outcome significantly.

Acquired Fanconi syndrome: Prognosis depends on underlying cause and extent of tubular damage. Jerky treat-associated and some drug-induced cases may be completely reversible with toxin removal and supportive care. Heavy metal toxicosis and severe nephrotoxicity carry guarded prognosis.

Category	Specific Causes
Nephrotoxic Drugs	Aminoglycosides (gentamicin), tetracyclines, cephalosporins, high-dose amoxicillin, cisplatin, streptozotocin
Heavy Metals	Lead, copper, mercury, cadmium, zinc (penny ingestion)
Toxins	Chinese jerky treats, melamine, maleic acid, organomercurials
Infections	Leptospirosis (important differential!)
Metabolic/Other	Copper-associated hepatopathy (Labrador Retrievers), hypoparathyroidism, amyloidosis, neoplasia

Renal Tubular Acidosis (RTA)

Renal tubular acidosis refers to a group of disorders characterized by normal anion gap (hyperchloremic) metabolic acidosis occurring in the setting of normal or only mildly reduced glomerular filtration rate. The acidosis results from defective tubular handling of bicarbonate or hydrogen ions.

Classification of Renal Tubular Acidosis

High-Yield Note - Differentiating RTA Types: Type 1 (Distal): Urine pH greater than 5.5 ALWAYS, severe acidosis (HCO3 less than 10), HYPOKALEMIA. Type 2 (Proximal): Can acidify urine once steady state reached, moderate acidosis (HCO3 15-18), usually with Fanconi findings. Type 4: HYPERKALEMIA is the key finding, mild acidosis, seen with hypoadrenocorticism or CKD.

Causes of Distal RTA (Type 1) in Dogs

Immune-mediated hemolytic anemia (IMHA) - important association
Drug-induced: amphotericin B, lithium, zonisamide
Ischemic injury (gastric dilatation-volvulus, shock)
Acute pancreatitis-associated AKI
Primary hyperparathyroidism
Urinary tract obstruction

Treatment of Renal Tubular Acidosis

Clinical Sign	Pathophysiological Mechanism
Polyuria/Polydipsia (MOST COMMON)	Glucosuria causes osmotic diuresis; impaired medullary concentration gradient
Weight loss despite normal appetite	Loss of glucose and amino acids in urine; metabolic acidosis-induced catabolism
Muscle weakness/lethargy	Hypokalemia; metabolic acidosis; hypophosphatemia
Poor body condition/muscle wasting	Chronic amino acid losses; protein catabolism from acidosis
Dehydration	Polyuria exceeds polydipsic compensation
Bone pain (rare, young dogs)	Phosphate wasting leads to rickets/osteomalacia

Nephrogenic Diabetes Insipidus (NDI)

Nephrogenic diabetes insipidus occurs when the collecting duct cells fail to respond appropriately to antidiuretic hormone (ADH/vasopressin), resulting in inability to concentrate urine. This is a disorder of distal tubular/collecting duct function.

Causes of Nephrogenic Diabetes Insipidus

Clinical Features and Diagnosis

Hallmark: Profound polyuria and polydipsia (water intake greater than 100 mL/kg/day)
Urine specific gravity: Persistently hyposthenuric (less than 1.006) to isosthenuric
DDAVP response test: NO response (no increase in USG) differentiates from central DI
Water deprivation test: Historically used but potentially dangerous; largely replaced by DDAVP trial

Treatment of Nephrogenic Diabetes Insipidus

Treat underlying cause (hypercalcemia, hypokalemia, infection, etc.)
Ensure free access to water - restriction causes life-threatening dehydration
Thiazide diuretics (hydrochlorothiazide 2 mg/kg PO BID): Paradoxically reduce urine output by 30-50%
Low-sodium diet enhances thiazide effect

NAVLE TipWhen differentiating causes of PU/PD with dilute urine: USG less than 1.006 (hyposthenuria) suggests active dilution and rules out renal insufficiency as the primary cause. Think of diabetes insipidus (central or nephrogenic), psychogenic polydipsia, or hyperadrenocorticism. USG 1.008-1.012 (isosthenuria) is more consistent with renal insufficiency where the kidney can neither concentrate nor dilute.

Test	Expected Findings	Clinical Significance
Urinalysis	Glucosuria (1+ to 4+); low USG (less than 1.030); pH alkaline or variable; mild proteinuria	Glucosuria often FIRST abnormality detected; precedes other markers
Serum Chemistry	Normal glucose; hypokalemia (approximately 33%); hypophosphatemia; hyperchloremia; normal to elevated BUN/creatinine	Hypophosphatemia differentiates from typical CKD (which shows hyperphosphatemia)
Venous Blood Gas	Metabolic acidosis; low bicarbonate; normal anion gap (hyperchloremic)	Essential for characterizing severity; guides bicarbonate supplementation
Urinary Amino Acids	Generalized aminoaciduria (multiple amino acids elevated)	Confirms generalized proximal tubular dysfunction; specialized testing
Genetic Testing	FAN1 gene mutation (Basenjis): Normal, Carrier, or Affected	Available through OFA; identifies dogs before clinical signs; allows informed breeding decisions

Acute Tubular Necrosis (ATN)

Acute tubular necrosis is the most common intrinsic cause of acute kidney injury (AKI). It results from ischemic or nephrotoxic injury to tubular epithelial cells, primarily affecting the metabolically active proximal tubule and thick ascending limb.

Causes of ATN in Dogs

Aminoglycoside Nephrotoxicity - High-Yield Topic

Aminoglycosides (gentamicin, amikacin) cause nephrotoxicity in 10-30% of therapeutic courses. The mechanism involves:

Glomerular filtration followed by uptake into PCT cells via megalin-cubilin receptor
Accumulation in lysosomes causing phospholipidosis and myeloid body formation
Cell necrosis and sloughing into tubular lumen
Characteristic finding: nonoliguric AKI with slow creatinine rise

High-Yield Note - Aminoglycoside Toxicity Prevention: Risk factors include dehydration, concurrent NSAID use, pre-existing renal disease, and prolonged therapy. Once-daily dosing may reduce nephrotoxicity by allowing drug-free periods for tubular recovery. Monitor trough levels (should be less than 1-2 mcg/mL) and serum creatinine. Avoid furosemide co-administration - it may enhance aminoglycoside nephrotoxicity.

Diagnostic Findings in ATN

Urinalysis: Granular (muddy brown) casts - classic finding; tubular epithelial cells; low USG
Fractional excretion of sodium (FENa): Greater than 2-3% (tubules cannot reabsorb Na); helps differentiate from prerenal azotemia
Serum biochemistry: Rapidly rising BUN/creatinine; hyperkalemia; hyperphosphatemia
Imaging: Normal to enlarged kidneys; normal echogenicity initially (may not see lesions on ultrasound)

Treatment	Dosing/Protocol	Monitoring
Bicarbonate Supplementation	Sodium bicarbonate or potassium citrate; dose titrated to venous blood gas; may require greater than 10 mEq/kg/day for proximal RTA	Venous blood gas every 2-4 weeks initially; target HCO3 greater than 18 mEq/L
Potassium Supplementation	Potassium citrate (preferred - provides K+ and alkalinization); potassium gluconate if acidosis not severe	Serum K+ levels; watch for hypokalemia with bicarbonate therapy
Phosphate Supplementation	If hypophosphatemic; aluminum-free phosphate binders may be needed if CKD progresses	Serum phosphorus; balance with secondary renal disease
Nutritional Support	High-quality protein; amino acid supplementation if indicated; renal diet if CKD present	Body weight; body condition score; muscle mass
Address Underlying Cause	Remove toxin/drug; treat leptospirosis; discontinue jerky treats; chelation for heavy metals	May see improvement in acquired forms

Type	Defect Location	Pathophysiology	Key Features
Type 1 (Distal)	Collecting duct alpha-intercalated cells	Impaired H+ secretion; cannot acidify urine below pH 5.5	Urine pH greater than 5.5 despite acidemia; hypokalemia; nephrolithiasis risk; HCO3 less than 10-12 mEq/L
Type 2 (Proximal)	Proximal tubule	Impaired HCO3 reabsorption; decreased Tm for bicarbonate	Usually occurs with Fanconi syndrome; can acidify urine; HCO3 15-18 mEq/L; requires high HCO3 doses
Type 4	Collecting duct (aldosterone effect)	Hypoaldosteronism or resistance; impaired K+ and H+ excretion	HYPERKALEMIA (distinguishing feature); mild acidosis; most common in CKD

RTA Type	Alkali Therapy	Additional Considerations
Type 1 (Distal)	1-3 mEq/kg/day sodium bicarbonate or potassium citrate	Potassium supplementation often needed; monitor for nephrocalcinosis
Type 2 (Proximal)	Greater than 10 mEq/kg/day (high doses needed due to ongoing urinary losses)	Treat underlying Fanconi syndrome; potassium wasting increases with HCO3 therapy
Type 4	Variable; often mild acidosis	TREAT HYPERKALEMIA first; fludrocortisone if hypoadrenocorticism; dietary K+ restriction

Category	Specific Causes
Primary (Congenital)	Very rare; defect in aquaporin-2 channels or V2 receptors; signs by 8-12 weeks of age
Electrolyte Disorders	Hypercalcemia (interferes with aquaporin-2); hypokalemia (impairs countercurrent mechanism)
Renal Disease	CKD (medullary washout); pyelonephritis; post-obstructive diuresis
Infectious	Leptospirosis (important! can cause tubular dysfunction and NDI)
Endocrine	Hyperadrenocorticism; hyperthyroidism (cats); hypoadrenocorticism
Other	Pyometra; liver disease; drugs (lithium, amphotericin B)

Category	Specific Causes and Notes
Ischemic	Hypotension, hypovolemia, shock, anesthesia, GDV, severe dehydration, cardiac failure, sepsis
Nephrotoxic Drugs	Aminoglycosides (accumulate in PCT lysosomes); NSAIDs; amphotericin B; cisplatin; cyclosporine
Toxins	Ethylene glycol (calcium oxalate crystals); grapes/raisins; lilies (cats); heavy metals; melamine
Pigment Nephropathy	Hemoglobinuria (IMHA, transfusion reactions); myoglobinuria (rhabdomyolysis, exertional, crush injury)
Infectious	Leptospirosis; babesiosis (hypotension-induced); pyelonephritis

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →